Clinical Trial Update: Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

View source ↗

Summary

This clinical trial compares 5.0T and 3.0T biparametric MRI for diagnosing prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Prostate Cancer | Status: RECRUITING